Postoperative Complications and Mortality With In-Hospital COVID-19 Omicron Infection After Surgery
Tangdu Hospital, Air Force Medical University
1 other identifier
observational
119
1 country
1
Brief Summary
Postoperative complications and mortality in patients with COVID-19 Omicron infection who have undergone specialized thoracic surgery are scarce. Subsequently, the patient cohort was divided into two groups for comparative analysis: Group 1 (G1), which comprised patients who acquired nosocomial omicron infection after surgery, and Group 2 (G2), which comprised patients who remained uninfected with omicron during their hospitalization period. Propensity score matching (PSM) analysis was conducted using the PSMATCH function in SPSS 27 to assess the incidence of perioperative complications and mortality rates between both groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2023
CompletedFirst Submitted
Initial submission to the registry
August 31, 2023
CompletedFirst Posted
Study publicly available on registry
September 15, 2023
CompletedSeptember 15, 2023
September 1, 2023
2 months
August 31, 2023
September 8, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Postoperative Complications
Postoperative Complications
up to 1 months
Postoperative Mortality
Postoperative Mortality
up to 1 months
Study Arms (2)
Group 1 (G1)
patients who acquired nosocomial omicron infection after surgery
Group 2 (G2)
patients who remained uninfected with omicron during their hospitalization period
Interventions
Thoracic Surgery Patients with In-Hospital COVID-19 Omicron Infection after surgery
Eligibility Criteria
Data of patients who underwent thoracic surgery at the Tangdu Hospital of Air Force Medical University and the Second Affiliated Hospital of Lanzhou University between December 1, 2022, and January 15, 2023, were collected.
You may qualify if:
- Data of patients who underwent thoracic surgery at the Tangdu Hospital of Air Force Medical University and the Second Affiliated Hospital of Lanzhou University between December 1, 2022, and January 15, 2023, were collected.
You may not qualify if:
- Non-surgery patients.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tang-Du Hospitallead
Study Sites (1)
The Second Affiliated Hospital of Air Force Medical University University of PLA
Xi'an, Shannxi, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Linna Liu
Tang-Du Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Deputy director
Study Record Dates
First Submitted
August 31, 2023
First Posted
September 15, 2023
Study Start
February 1, 2023
Primary Completion
March 31, 2023
Study Completion
March 31, 2023
Last Updated
September 15, 2023
Record last verified: 2023-09